Nanotherapies for Treatment of Cardiovascular Disease: A Case for Antioxidant Targeted Delivery

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cardiovascular Medicine

Background:

• Cardiovascular disease (CVD) is linked to excessive reactive oxygen and nitrogen species, causing vascular dysfunction.
• Antioxidant therapy is a potential treatment for CVD-related conditions.
• Systemic antioxidant delivery faces challenges, necessitating targeted approaches.

Purpose of the Study:

• To review nanotherapeutic strategies for targeting CVD.
• To explore successful pre-clinical studies of targeted nano-antioxidant therapy.

Main Methods:

• Literature review of nanotherapeutic options for CVD.
• Analysis of studies employing targeted nano-antioxidant delivery.

Main Results:

• Active targeting in CVD often involves immunotargeting inflammatory markers or extracellular matrix components.
• Targeted antioxidant nanotherapies have demonstrated success in pre-clinical research.

Conclusions:

• Targeted nanocarriers hold significant potential for the clinical translation of antioxidant therapies for CVD.
• This approach may overcome current limitations in treating vascular dysfunction and associated pathologies.